Dr. Devasena Gnanashanmugam, Senior Director Medical Affairs

EMPLOYMENT/ APPOINTMENTS:
Senior Director, Medical Affairs, Cepheid, Inc.

Adjunct Clinical Associate Professor, Department of Pediatrics, Stanford University, School of Medicine, May 2020- Present

SUMMARY OF QUALIFICATIONS:
Physician with clinical research experience in therapeutics and diagnostic from private, public, and academic sectors. Experience in clinical trials management, pharmacovigilance, protocol development, drug development, vaccine research, and regulatory submissions for adult and pediatric trials.  Managed over thirty HIV clinical trials in maternal and child health at the NIH. Designed global infectious diseases protocols as a physician lead in industry partnerships. Collaborated with government officials, key opinion leaders, and in- country staff in design and implementation of clinical trials. Presented at FDA meetings.

PROFESSIONAL TRAINING:
Fellow, Pediatric Infectious Diseases , Stanford University, CA, 2003-2007

Publications:
Armstrong, D. T., Fisher, S., Totten, M., Schwartz, M., Gnanashanmugam, D., & Parrish, N. (2022). Clinical Validation of the Xpert MTB/RIF test for Identification of the MTB Complex in AFB Smear-Positive MGIT broth cultures. Journal of Clinical Microbiology, JCM-02164.
Verma R, Patil S, Zhang N, Moreira FMF, Vitorio MT, Santos ADS, Wallace E, Gnanashanmugam D, Persing DH, Savic RM, Croda J, Andrews JR. A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1317-1326. doi: 10.1164/rccm.202103-0564OC. PMID: 34375564.